Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages
Yufei Zhang(Chang'an University), Guosong Chen(Fudan University), Libin Wu(Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Yiwei Chu(Fudan University), Zhen Li(South China Agricultural University), Weiyi Zhang(Fudan University)
Cited by 99
Related Papers
SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice
|Cell Reports|2017|340
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Lipid metabolism in inflammation-related diseases
|The Analyst|2018|183
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
|Cancer Immunology Research|2018|137